does glp 1 cause water retention Understanding Weight Regain After VSG and the Role of GLP-1 Medications Treatment with GLP-1 receptor agonists

Ethics approval and consent to participate This study was approved by the Institutional Review Board at Severance Hospital, Seoul, Korea (4-2014-0830) and all sample donors provided written informed consent

THE FIT PROGRAM INCLUDED ADULT PATIENTS WITH CHRONIC ITP WHO HAD RECEIVED 1 PRIOR THERAPY FIT program patients were representative of the general adult chronic ITP population, including exposure to prior therapies TAVALISSE dosing 3 Starting dose of TAVALISSE: One 100 mg tablet BID Based on platelet count and tolerability, the dose could be increased to one 150 mg tablet BID at or after week 4 Patients who had a platelet count 50 x 10 9 /L at the time of rollover to the FIT-3 open-label extension study maintained their existing dose of TAVALISSE References: 1

Understanding who should not take GLP-1 medications protects patient safety and ensures treatment aligns with medical history

These are normally boiled in a slow cooker for a long period of time (often 1 to 2 days)